Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$50,775,837
in 5 filings, $50.8M under 10b5-1 plans

Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-12 Hoge Stephen President Sale 10b5-1 −304 $86.23 $26K 1,516,281
2024-02-09 Hoge Stephen President Exercise or conversion 10b5-1 +522 1,516,585
2024-02-09 Hoge Stephen President Exercise or conversion · Restricted Stock Units 10b5-1 −522 2,090
2024-01-16 Hoge Stephen President Sale 10b5-1 −15,000 $103.90 $1.6M 1,516,063
2024-01-08 Mock James M Chief Financial Officer Sale 10b5-1 −772 $109.75 $85K 3,632
2024-01-05 Mock James M Chief Financial Officer Exercise or conversion 10b5-1 +1,452 4,404
2024-01-05 Mock James M Chief Financial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −1,452 15,980
2023-12-27 Hoge Stephen President Sale 10b5-1 −45,000 $100.01 $4.5M 1,531,063
2023-12-08 Klinger Shannon Thyme Chief Legal Officer Sale 10b5-1 −563 $79.09 $45K 7,912
2023-12-07 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion 10b5-1 +1,139 8,475
2023-12-07 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion · Restricted Stock Units 10b5-1 −1,139 6,832
2023-12-06 Garay Arpa Chief Commercial Officer Sale 10b5-1 −564 $78.34 $44K 3,690
2023-12-05 Garay Arpa Chief Commercial Officer Exercise or conversion 10b5-1 +1,141 4,254
2023-12-05 Garay Arpa Chief Commercial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −1,141 11,405
2023-12-04 Klinger Shannon Thyme Chief Legal Officer Sale 10b5-1 −111 $79.31 $9K 7,336
2023-12-04 Hoge Stephen President Sale 10b5-1 −309 $79.31 $25K 1,576,063
2023-12-01 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion 10b5-1 +232 7,447
2023-12-01 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion · Restricted Stock Units 10b5-1 −232 2,094
2023-12-01 Hoge Stephen President Exercise or conversion 10b5-1 +651 1,576,372
2023-12-01 Hoge Stephen President Exercise or conversion · Restricted Stock Units 10b5-1 −651 5,865

Page 36 of 38 · 743 trades